Migraine Briefs

Nonpharmacological interventions can effectively treat pediatric migraine


 

Key clinical point: Components of nonpharmacological interventions are effective for treatment of pediatric migraine.

Major finding: Short-term self-administered treatments (standardized mean difference [SMD], 1.44; 95% confidence interval [95% CI], 0.26-2.62), biofeedback (SMD, 1.41; 95% CI, 0.64-2.17), relaxation (SMD, 1.38; 95% CI, 0.61-2.14), and psychological treatments (SMD, 1.36; 95% CI, 0.15-2.57) were more effective than the waiting list, with findings being similar for long-term treatments.

Study details: A network meta-analysis of 12 randomized clinical trials that evaluated nonpharmacological treatments for pediatric migraine in 576 children and adolescents with episodic migraine.

Disclosures: The study was supported in part by the Sara Page Mayo Endowment for Pediatric Pain Research, Education, and Treatment. The authors reported no potential conflicts of interest.

Source: Koechlin H et al. Pediatrics. 2021 Mar 9. doi: 10.1542/peds.2019-4107 .

Recommended Reading

Ubrogepant safety and efficacy not affected by triptan therapy
Migraine ICYMI
Migraine: Anti-CGRP mAbs beneficial in partial and nonresponders to onabotulinumtoxinA
Migraine ICYMI
Prior exposure and response to triptans may not affect efficacy of ubrogepant
Migraine ICYMI
Celecoxib oral solution shows promise for acute treatment of migraine
Migraine ICYMI
Poor sleep and stress linked to higher headache recurrence in episodic migraine
Migraine ICYMI
Migraineurs not taking advantage of an ‘effective prophylactic’
Migraine ICYMI
Rimegepant looks safe in migraine patients with cardiovascular risk
Migraine ICYMI
Investigative gepant liver profile comparable with standard of care
Migraine ICYMI
Cannabis for migraine strongly linked to rebound headache
Migraine ICYMI
Intranasal third-generation CGRP effective for acute migraine
Migraine ICYMI